These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23262436)

  • 21. A distinct subset of HLA-DR+-regulatory T cells is involved in the induction of preterm labor during pregnancy and in the induction of organ rejection after transplantation.
    Kisielewicz A; Schaier M; Schmitt E; Hug F; Haensch GM; Meuer S; Zeier M; Sohn C; Steinborn A
    Clin Immunol; 2010 Nov; 137(2):209-20. PubMed ID: 20822960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The extent of HLA-DR expression on HLA-DR(+) Tregs allows the identification of patients with clinically relevant borderline rejection.
    Schaier M; Seissler N; Becker LE; Schaefer SM; Schmitt E; Meuer S; Hug F; Sommerer C; Waldherr R; Zeier M; Steinborn A
    Transpl Int; 2013 Mar; 26(3):290-9. PubMed ID: 23279010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity of transplant chronic rejection correlates with level of graft-infiltrating regulatory cells.
    Semiletova NV; Shen XD; Baibakov B; Andakyan A
    J Heart Lung Transplant; 2010 Mar; 29(3):335-41. PubMed ID: 20080050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory T-cell activation among patients who displayed operational tolerance following intra-portal administration of donor-specific antigens in living donor liver transplantation.
    Sato Y; Chikako T; Oya H; Yamamoto S; Kokai H; Miura K; Hatakeyama K
    Transplant Proc; 2012 Mar; 44(2):560-4. PubMed ID: 22410069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dynamic changes of Th17/Treg cytokines in rat liver transplant rejection and tolerance.
    Li J; Lai X; Liao W; He Y; Liu Y; Gong J
    Int Immunopharmacol; 2011 Aug; 11(8):962-7. PubMed ID: 21376155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct expression of interleukin 17, tumor necrosis factor α, transforming growth factor β, and forkhead box P3 in acute rejection after kidney transplantation.
    de Menezes Neves PD; Machado JR; dos Reis MA; Faleiros AC; de Lima Pereira SA; Rodrigues DB
    Ann Diagn Pathol; 2013 Feb; 17(1):75-9. PubMed ID: 22963863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
    Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review.
    Herrera-Gómez F; Del Aguila W; Tejero-Pedregosa A; Adler M; Padilla-Berdugo R; Maurtua-Briseño-Meiggs Á; Pascual J; Pascual M; San Segundo D; Heidt S; Álvarez FJ; Ochoa-Sangrador C; Lambert C
    Int Immunopharmacol; 2018 Dec; 65():483-492. PubMed ID: 30390595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory T cells and T cell depletion: role of immunosuppressive drugs.
    Noris M; Casiraghi F; Todeschini M; Cravedi P; Cugini D; Monteferrante G; Aiello S; Cassis L; Gotti E; Gaspari F; Cattaneo D; Perico N; Remuzzi G
    J Am Soc Nephrol; 2007 Mar; 18(3):1007-18. PubMed ID: 17287424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoregulation and tolerance.
    Knechtle SJ
    Transplant Proc; 2010 Nov; 42(9 Suppl):S13-5. PubMed ID: 21095443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis.
    Zuber J; Brodin-Sartorius A; Lapidus N; Patey N; Tosolini M; Candon S; Rabant M; Snanoudj R; Panterne C; Thervet E; Legendre C; Chatenoud L
    Nephrol Dial Transplant; 2009 Dec; 24(12):3847-54. PubMed ID: 19729462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential monocyte STAT6 activation and CD4(+)CD25(+)Foxp3(+) T cells in kidney operational tolerance transplanted individuals.
    Moraes-Vieira PM; Silva HM; Takenaka MC; Monteiro SM; Lemos F; Saitovitch D; Kalil J; Coelho V
    Hum Immunol; 2010 May; 71(5):442-50. PubMed ID: 20122976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forkhead box protein 3 mRNA expression in the peripheral blood of kidney-transplant recipients with acute rejection.
    Wang W; Li XB; Yang XY; Zhang XD
    Chin Med J (Engl); 2011 Jun; 124(12):1775-8. PubMed ID: 21740831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatory T-cells in patients after kidney transplantation.
    van de Wetering J; Koumoutsakos P; Peeters A; van der Mast BJ; de Kuiper P; IJzermans JN; Weimar W; Baan CC
    Clin Transplant; 2011; 25(1):40-6. PubMed ID: 20636406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T regulatory cells in xenotransplantation.
    Muller YD; Golshayan D; Ehirchiou D; Wekerle T; Seebach JD; Bühler LH
    Xenotransplantation; 2009; 16(3):121-8. PubMed ID: 19566651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival.
    Wolf D; Schreiber TH; Tryphonopoulos P; Li S; Tzakis AG; Ruiz P; Podack ER
    Transplantation; 2012 Sep; 94(6):569-74. PubMed ID: 22902792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of regulatory T cells and FoxP3-positive T-cell subsets in the peripheral blood of renal transplant recipients with sirolimus versus cyclosporine: a preliminary study.
    Zhao T; Yang C; Qiu Y; Xue Y; Zhao Z; Song D; Qiu Y; Ma Z; Yang B; Xu M; Rong R; Zhu T
    Transplant Proc; 2013; 45(1):148-52. PubMed ID: 23375289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD.
    Koenecke C; Czeloth N; Bubke A; Schmitz S; Kissenpfennig A; Malissen B; Huehn J; Ganser A; Förster R; Prinz I
    Eur J Immunol; 2009 Nov; 39(11):3091-6. PubMed ID: 19750478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.